|
× |
 |
Effects of Antipsychotics on Secular Mortality Trends in Patients With Alzheimer's Disease PDF |
$40.00 |
|
$40.00 |
|
× |
|
Long-term Outcomes of Early Use of Long-Acting Injectable Antipsychotics in Schizophrenia PDF |
$40.00 |
|
$40.00 |
|
× |
|
Quetiapine and Drug Interactions: Evidence From a Routine Therapeutic Drug Monitoring Service PDF |
$40.00 |
|
$40.00 |
|
× |
|
Adjunctive Fluvoxamine Inhibits Clozapine-Related Weight Gain and Metabolic Disturbances PDF |
$40.00 |
|
$40.00 |
|
× |
|
Childhood Trauma Is Associated With Severe Clinical Characteristics of Bipolar Disorders PDF |
$40.00 |
|
$40.00 |
|
× |
|
Clinical Differences Between Suicidal and Nonsuicidal Depressed Children and Adolescents PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Case of Dramatic Improvement of Severe Tardive Dyskinesia After Switch to Aripiprazole PDF |
$40.00 |
|
$40.00 |
|
× |
|
Psychiatric Comorbidity in Hospitalized Adolescents With Borderline Personality Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Pilot Trial of Ondansetron in the Treatment of 8 Patients With Obsessive-Compulsive Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Ziprasidone in Treatment-Resistant Schizophrenia: A 52-Week, Open-Label Continuation Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
Security of Electronic Mental Health Communication and Record-Keeping in the Digital Age PDF |
$40.00 |
|
$40.00 |
|
× |
|
Bupropion for Patients With Obsessive-Compulsive Disorder: An Open-Label, Fixed-Dose Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
Citalopram Intravenous Infusion in Resistant Obsessive-Compulsive Disorder: An Open Trial PDF |
$40.00 |
|
$40.00 |
|
× |
|
Adherence Assessments and the Use of Depot Antipsychotics in Patients With Schizophrenia. PDF |
$40.00 |
|
$40.00 |
|
|
